Israel-based DreaMed Diabetes announced this week that it has raised $3.3 million from Norma Investments, Russian businessman Roman Abramovich and one other unnamed angel. The funds will mainly be ...

Out of the diabetes patients surveyed, 46% said they would feel more in control of their disease in everyday life if they could identify trends before they turn into problems.

DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies' market shares, challenges, diabetes ...

The company’s eGlycemic Management System ® featuring Glucommander™ has the broadest indications for use of any decision support solution for insulin titration. WALTHAM, Mass.--(BUSINESS WIRE)--The ...

GERMANTOWN, Md. and PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. and Ascensia Diabetes Care announce the software integration of SweetSpot™ with the Eversense ® 365 ...

Paris, France-based Voluntis, a developer of companion apps for medical devices, has raised $29 million in its fourth round of funding. The round was led by Bpifrance Large Venture and international ...

The FDA granted a De Novo request for DreaMed Diabetes’ artificial intelligence-based decision support software Advisor Pro, the Israeli diabetes management solutions developer confirmed June 18.

Roche Diabetes Care recalled its Accu-Chek Connect diabetes management app over software issues, according to an FDA safety alert issued Feb. 15. 1. Certain iOS and Android versions of the app contain ...

The $3.6 million FREEDOM—Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management—study focuses on sustainable and effective Type 2 diabetes management ...